 | • レポートコード：MRC2-11QY03864 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、91ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は多発性骨髄腫治療薬のグローバル市場について調査・分析したレポートです。種類別（化学療法・その他の薬剤、放射線、幹細胞移植、その他の支持療法）市場規模、用途別（病院、診療所、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別多発性骨髄腫治療薬の競争状況、市場シェア ・世界の多発性骨髄腫治療薬市場：種類別市場規模 2015年-2020年（化学療法・その他の薬剤、放射線、幹細胞移植、その他の支持療法） ・世界の多発性骨髄腫治療薬市場：種類別市場規模予測 2021年-2026年（化学療法・その他の薬剤、放射線、幹細胞移植、その他の支持療法） ・世界の多発性骨髄腫治療薬市場：用途別市場規模 2015年-2020年（病院、診療所、その他） ・世界の多発性骨髄腫治療薬市場：用途別市場規模予測 2021年-2026年（病院、診療所、その他） ・北米の多発性骨髄腫治療薬市場分析：米国、カナダ ・ヨーロッパの多発性骨髄腫治療薬市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの多発性骨髄腫治療薬市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の多発性骨髄腫治療薬市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの多発性骨髄腫治療薬市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Janssen Biotech, Inc.、Bristol-Myers Squibb、Novartis AG、Bristol-Myers Squibb Company、Millennium Pharmaceuticals、Celgene Corporation、Kesios Therapeutics Limited、Amgene, Inc.、Genzyme Corporation、Juno Therapeutics ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Multiple Myeloma (MM) is a haematological malignancy considered by the propagation of plasma cells in the bone marrow. The disease is incurable; though over the few years there have been substantial developments in therapy, determined by a greater understanding of pathophysiology. Multiple myeloma is common among men as compared to women and also arises commonly with growing age.
Market Analysis and Insights: Global Multiple Myeloma Therapeutics Market
The global Multiple Myeloma Therapeutics market size is projected to reach US$ 30460 million by 2026, from US$ 27270 million in 2020, at a CAGR of 10.6%% during 2021-2026.
Global Multiple Myeloma Therapeutics Scope and Market Size
Multiple Myeloma Therapeutics market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Multiple Myeloma Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Janssen Biotech, Inc.
Bristol-Myers Squibb
Novartis AG
Bristol-Myers Squibb Company
Millennium Pharmaceuticals
Celgene Corporation
Kesios Therapeutics Limited
Amgene, Inc.
Genzyme Corporation
Juno Therapeutics
Market segment by Type, the product can be split into
Chemotherapy And Other Drugs
Radiation
Stem Cell Transplant
Other Supportive Treatments
Market segment by Application, split into
Hospitals
Clinics
Others
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Multiple Myeloma Therapeutics Revenue
1.4 Market by Type
1.4.1 Global Multiple Myeloma Therapeutics Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Chemotherapy And Other Drugs
1.4.3 Radiation
1.4.4 Stem Cell Transplant
1.4.5 Other Supportive Treatments
1.5 Market by Application
1.5.1 Global Multiple Myeloma Therapeutics Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Multiple Myeloma Therapeutics Market Perspective (2015-2026)
2.2 Global Multiple Myeloma Therapeutics Growth Trends by Regions
2.2.1 Multiple Myeloma Therapeutics Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Multiple Myeloma Therapeutics Historic Market Share by Regions (2015-2020)
2.2.3 Multiple Myeloma Therapeutics Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Multiple Myeloma Therapeutics Market Growth Strategy
2.3.6 Primary Interviews with Key Multiple Myeloma Therapeutics Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Multiple Myeloma Therapeutics Players by Market Size
3.1.1 Global Top Multiple Myeloma Therapeutics Players by Revenue (2015-2020)
3.1.2 Global Multiple Myeloma Therapeutics Revenue Market Share by Players (2015-2020)
3.1.3 Global Multiple Myeloma Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Multiple Myeloma Therapeutics Market Concentration Ratio
3.2.1 Global Multiple Myeloma Therapeutics Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Multiple Myeloma Therapeutics Revenue in 2019
3.3 Multiple Myeloma Therapeutics Key Players Head office and Area Served
3.4 Key Players Multiple Myeloma Therapeutics Product Solution and Service
3.5 Date of Enter into Multiple Myeloma Therapeutics Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Multiple Myeloma Therapeutics Historic Market Size by Type (2015-2020)
4.2 Global Multiple Myeloma Therapeutics Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Multiple Myeloma Therapeutics Market Size by Application (2015-2020)
5.2 Global Multiple Myeloma Therapeutics Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Multiple Myeloma Therapeutics Market Size (2015-2020)
6.2 Multiple Myeloma Therapeutics Key Players in North America (2019-2020)
6.3 North America Multiple Myeloma Therapeutics Market Size by Type (2015-2020)
6.4 North America Multiple Myeloma Therapeutics Market Size by Application (2015-2020)
7 Europe
7.1 Europe Multiple Myeloma Therapeutics Market Size (2015-2020)
7.2 Multiple Myeloma Therapeutics Key Players in Europe (2019-2020)
7.3 Europe Multiple Myeloma Therapeutics Market Size by Type (2015-2020)
7.4 Europe Multiple Myeloma Therapeutics Market Size by Application (2015-2020)
8 China
8.1 China Multiple Myeloma Therapeutics Market Size (2015-2020)
8.2 Multiple Myeloma Therapeutics Key Players in China (2019-2020)
8.3 China Multiple Myeloma Therapeutics Market Size by Type (2015-2020)
8.4 China Multiple Myeloma Therapeutics Market Size by Application (2015-2020)
9 Japan
9.1 Japan Multiple Myeloma Therapeutics Market Size (2015-2020)
9.2 Multiple Myeloma Therapeutics Key Players in Japan (2019-2020)
9.3 Japan Multiple Myeloma Therapeutics Market Size by Type (2015-2020)
9.4 Japan Multiple Myeloma Therapeutics Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Multiple Myeloma Therapeutics Market Size (2015-2020)
10.2 Multiple Myeloma Therapeutics Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Multiple Myeloma Therapeutics Market Size by Type (2015-2020)
10.4 Southeast Asia Multiple Myeloma Therapeutics Market Size by Application (2015-2020)
11 India
11.1 India Multiple Myeloma Therapeutics Market Size (2015-2020)
11.2 Multiple Myeloma Therapeutics Key Players in India (2019-2020)
11.3 India Multiple Myeloma Therapeutics Market Size by Type (2015-2020)
11.4 India Multiple Myeloma Therapeutics Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Multiple Myeloma Therapeutics Market Size (2015-2020)
12.2 Multiple Myeloma Therapeutics Key Players in Central & South America (2019-2020)
12.3 Central & South America Multiple Myeloma Therapeutics Market Size by Type (2015-2020)
12.4 Central & South America Multiple Myeloma Therapeutics Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Janssen Biotech, Inc.
13.1.1 Janssen Biotech, Inc. Company Details
13.1.2 Janssen Biotech, Inc. Business Overview
13.1.3 Janssen Biotech, Inc. Multiple Myeloma Therapeutics Introduction
13.1.4 Janssen Biotech, Inc. Revenue in Multiple Myeloma Therapeutics Business (2015-2020))
13.1.5 Janssen Biotech, Inc. Recent Development
13.2 Bristol-Myers Squibb
13.2.1 Bristol-Myers Squibb Company Details
13.2.2 Bristol-Myers Squibb Business Overview
13.2.3 Bristol-Myers Squibb Multiple Myeloma Therapeutics Introduction
13.2.4 Bristol-Myers Squibb Revenue in Multiple Myeloma Therapeutics Business (2015-2020)
13.2.5 Bristol-Myers Squibb Recent Development
13.3 Novartis AG
13.3.1 Novartis AG Company Details
13.3.2 Novartis AG Business Overview
13.3.3 Novartis AG Multiple Myeloma Therapeutics Introduction
13.3.4 Novartis AG Revenue in Multiple Myeloma Therapeutics Business (2015-2020)
13.3.5 Novartis AG Recent Development
13.4 Bristol-Myers Squibb Company
13.4.1 Bristol-Myers Squibb Company Company Details
13.4.2 Bristol-Myers Squibb Company Business Overview
13.4.3 Bristol-Myers Squibb Company Multiple Myeloma Therapeutics Introduction
13.4.4 Bristol-Myers Squibb Company Revenue in Multiple Myeloma Therapeutics Business (2015-2020)
13.4.5 Bristol-Myers Squibb Company Recent Development
13.5 Millennium Pharmaceuticals
13.5.1 Millennium Pharmaceuticals Company Details
13.5.2 Millennium Pharmaceuticals Business Overview
13.5.3 Millennium Pharmaceuticals Multiple Myeloma Therapeutics Introduction
13.5.4 Millennium Pharmaceuticals Revenue in Multiple Myeloma Therapeutics Business (2015-2020)
13.5.5 Millennium Pharmaceuticals Recent Development
13.6 Celgene Corporation
13.6.1 Celgene Corporation Company Details
13.6.2 Celgene Corporation Business Overview
13.6.3 Celgene Corporation Multiple Myeloma Therapeutics Introduction
13.6.4 Celgene Corporation Revenue in Multiple Myeloma Therapeutics Business (2015-2020)
13.6.5 Celgene Corporation Recent Development
13.7 Kesios Therapeutics Limited
13.7.1 Kesios Therapeutics Limited Company Details
13.7.2 Kesios Therapeutics Limited Business Overview
13.7.3 Kesios Therapeutics Limited Multiple Myeloma Therapeutics Introduction
13.7.4 Kesios Therapeutics Limited Revenue in Multiple Myeloma Therapeutics Business (2015-2020)
13.7.5 Kesios Therapeutics Limited Recent Development
13.8 Amgene, Inc.
13.8.1 Amgene, Inc. Company Details
13.8.2 Amgene, Inc. Business Overview
13.8.3 Amgene, Inc. Multiple Myeloma Therapeutics Introduction
13.8.4 Amgene, Inc. Revenue in Multiple Myeloma Therapeutics Business (2015-2020)
13.8.5 Amgene, Inc. Recent Development
13.9 Genzyme Corporation
13.9.1 Genzyme Corporation Company Details
13.9.2 Genzyme Corporation Business Overview
13.9.3 Genzyme Corporation Multiple Myeloma Therapeutics Introduction
13.9.4 Genzyme Corporation Revenue in Multiple Myeloma Therapeutics Business (2015-2020)
13.9.5 Genzyme Corporation Recent Development
13.10 Juno Therapeutics
13.10.1 Juno Therapeutics Company Details
13.10.2 Juno Therapeutics Business Overview
13.10.3 Juno Therapeutics Multiple Myeloma Therapeutics Introduction
13.10.4 Juno Therapeutics Revenue in Multiple Myeloma Therapeutics Business (2015-2020)
13.10.5 Juno Therapeutics Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Multiple Myeloma Therapeutics Key Market Segments
Table 2. Key Players Covered: Ranking by Multiple Myeloma Therapeutics Revenue
Table 3. Ranking of Global Top Multiple Myeloma Therapeutics Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Multiple Myeloma Therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Chemotherapy And Other Drugs
Table 6. Key Players of Radiation
Table 7. Key Players of Stem Cell Transplant
Table 8. Key Players of Other Supportive Treatments
Table 9. Global Multiple Myeloma Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 10. Global Multiple Myeloma Therapeutics Market Size by Regions (US$ Million): 2020 VS 2026
Table 11. Global Multiple Myeloma Therapeutics Market Size by Regions (2015-2020) (US$ Million)
Table 12. Global Multiple Myeloma Therapeutics Market Share by Regions (2015-2020)
Table 13. Global Multiple Myeloma Therapeutics Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 14. Global Multiple Myeloma Therapeutics Market Share by Regions (2021-2026)
Table 15. Market Top Trends
Table 16. Key Drivers: Impact Analysis
Table 17. Key Challenges
Table 18. Multiple Myeloma Therapeutics Market Growth Strategy
Table 19. Main Points Interviewed from Key Multiple Myeloma Therapeutics Players
Table 20. Global Multiple Myeloma Therapeutics Revenue by Players (2015-2020) (Million US$)
Table 21. Global Multiple Myeloma Therapeutics Market Share by Players (2015-2020)
Table 22. Global Top Multiple Myeloma Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Multiple Myeloma Therapeutics as of 2019)
Table 23. Global Multiple Myeloma Therapeutics by Players Market Concentration Ratio (CR5 and HHI)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players Multiple Myeloma Therapeutics Product Solution and Service
Table 26. Date of Enter into Multiple Myeloma Therapeutics Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Multiple Myeloma Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 29. Global Multiple Myeloma Therapeutics Market Size Share by Type (2015-2020)
Table 30. Global Multiple Myeloma Therapeutics Revenue Market Share by Type (2021-2026)
Table 31. Global Multiple Myeloma Therapeutics Market Size Share by Application (2015-2020)
Table 32. Global Multiple Myeloma Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 33. Global Multiple Myeloma Therapeutics Market Size Share by Application (2021-2026)
Table 34. North America Key Players Multiple Myeloma Therapeutics Revenue (2019-2020) (Million US$)
Table 35. North America Key Players Multiple Myeloma Therapeutics Market Share (2019-2020)
Table 36. North America Multiple Myeloma Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 37. North America Multiple Myeloma Therapeutics Market Share by Type (2015-2020)
Table 38. North America Multiple Myeloma Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 39. North America Multiple Myeloma Therapeutics Market Share by Application (2015-2020)
Table 40. Europe Key Players Multiple Myeloma Therapeutics Revenue (2019-2020) (Million US$)
Table 41. Europe Key Players Multiple Myeloma Therapeutics Market Share (2019-2020)
Table 42. Europe Multiple Myeloma Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 43. Europe Multiple Myeloma Therapeutics Market Share by Type (2015-2020)
Table 44. Europe Multiple Myeloma Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 45. Europe Multiple Myeloma Therapeutics Market Share by Application (2015-2020)
Table 46. China Key Players Multiple Myeloma Therapeutics Revenue (2019-2020) (Million US$)
Table 47. China Key Players Multiple Myeloma Therapeutics Market Share (2019-2020)
Table 48. China Multiple Myeloma Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 49. China Multiple Myeloma Therapeutics Market Share by Type (2015-2020)
Table 50. China Multiple Myeloma Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 51. China Multiple Myeloma Therapeutics Market Share by Application (2015-2020)
Table 52. Japan Key Players Multiple Myeloma Therapeutics Revenue (2019-2020) (Million US$)
Table 53. Japan Key Players Multiple Myeloma Therapeutics Market Share (2019-2020)
Table 54. Japan Multiple Myeloma Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 55. Japan Multiple Myeloma Therapeutics Market Share by Type (2015-2020)
Table 56. Japan Multiple Myeloma Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 57. Japan Multiple Myeloma Therapeutics Market Share by Application (2015-2020)
Table 58. Southeast Asia Key Players Multiple Myeloma Therapeutics Revenue (2019-2020) (Million US$)
Table 59. Southeast Asia Key Players Multiple Myeloma Therapeutics Market Share (2019-2020)
Table 60. Southeast Asia Multiple Myeloma Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 61. Southeast Asia Multiple Myeloma Therapeutics Market Share by Type (2015-2020)
Table 62. Southeast Asia Multiple Myeloma Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 63. Southeast Asia Multiple Myeloma Therapeutics Market Share by Application (2015-2020)
Table 64. India Key Players Multiple Myeloma Therapeutics Revenue (2019-2020) (Million US$)
Table 65. India Key Players Multiple Myeloma Therapeutics Market Share (2019-2020)
Table 66. India Multiple Myeloma Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 67. India Multiple Myeloma Therapeutics Market Share by Type (2015-2020)
Table 68. India Multiple Myeloma Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 69. India Multiple Myeloma Therapeutics Market Share by Application (2015-2020)
Table 70. Central & South America Key Players Multiple Myeloma Therapeutics Revenue (2019-2020) (Million US$)
Table 71. Central & South America Key Players Multiple Myeloma Therapeutics Market Share (2019-2020)
Table 72. Central & South America Multiple Myeloma Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 73. Central & South America Multiple Myeloma Therapeutics Market Share by Type (2015-2020)
Table 74. Central & South America Multiple Myeloma Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 75. Central & South America Multiple Myeloma Therapeutics Market Share by Application (2015-2020)
Table 76. Janssen Biotech, Inc. Company Details
Table 77. Janssen Biotech, Inc. Business Overview
Table 78. Janssen Biotech, Inc. Product
Table 79. Janssen Biotech, Inc. Revenue in Multiple Myeloma Therapeutics Business (2015-2020) (Million US$)
Table 80. Janssen Biotech, Inc. Recent Development
Table 81. Bristol-Myers Squibb Company Details
Table 82. Bristol-Myers Squibb Business Overview
Table 83. Bristol-Myers Squibb Product
Table 84. Bristol-Myers Squibb Revenue in Multiple Myeloma Therapeutics Business (2015-2020) (Million US$)
Table 85. Bristol-Myers Squibb Recent Development
Table 86. Novartis AG Company Details
Table 87. Novartis AG Business Overview
Table 88. Novartis AG Product
Table 89. Novartis AG Revenue in Multiple Myeloma Therapeutics Business (2015-2020) (Million US$)
Table 90. Novartis AG Recent Development
Table 91. Bristol-Myers Squibb Company Company Details
Table 92. Bristol-Myers Squibb Company Business Overview
Table 93. Bristol-Myers Squibb Company Product
Table 94. Bristol-Myers Squibb Company Revenue in Multiple Myeloma Therapeutics Business (2015-2020) (Million US$)
Table 95. Bristol-Myers Squibb Company Recent Development
Table 96. Millennium Pharmaceuticals Company Details
Table 97. Millennium Pharmaceuticals Business Overview
Table 98. Millennium Pharmaceuticals Product
Table 99. Millennium Pharmaceuticals Revenue in Multiple Myeloma Therapeutics Business (2015-2020) (Million US$)
Table 100. Millennium Pharmaceuticals Recent Development
Table 101. Celgene Corporation Company Details
Table 102. Celgene Corporation Business Overview
Table 103. Celgene Corporation Product
Table 104. Celgene Corporation Revenue in Multiple Myeloma Therapeutics Business (2015-2020) (Million US$)
Table 105. Celgene Corporation Recent Development
Table 106. Kesios Therapeutics Limited Company Details
Table 107. Kesios Therapeutics Limited Business Overview
Table 108. Kesios Therapeutics Limited Product
Table 109. Kesios Therapeutics Limited Revenue in Multiple Myeloma Therapeutics Business (2015-2020) (Million US$)
Table 110. Kesios Therapeutics Limited Recent Development
Table 111. Amgene, Inc. Business Overview
Table 112. Amgene, Inc. Product
Table 113. Amgene, Inc. Company Details
Table 114. Amgene, Inc. Revenue in Multiple Myeloma Therapeutics Business (2015-2020) (Million US$)
Table 115. Amgene, Inc. Recent Development
Table 116. Genzyme Corporation Company Details
Table 117. Genzyme Corporation Business Overview
Table 118. Genzyme Corporation Product
Table 119. Genzyme Corporation Revenue in Multiple Myeloma Therapeutics Business (2015-2020) (Million US$)
Table 120. Genzyme Corporation Recent Development
Table 121. Juno Therapeutics Company Details
Table 122. Juno Therapeutics Business Overview
Table 123. Juno Therapeutics Product
Table 124. Juno Therapeutics Revenue in Multiple Myeloma Therapeutics Business (2015-2020) (Million US$)
Table 125. Juno Therapeutics Recent Development
Table 126. Research Programs/Design for This Report
Table 127. Key Data Information from Secondary Sources
Table 128. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Multiple Myeloma Therapeutics Market Share by Type: 2020 VS 2026
Figure 2. Chemotherapy And Other Drugs Features
Figure 3. Radiation Features
Figure 4. Stem Cell Transplant Features
Figure 5. Other Supportive Treatments Features
Figure 6. Global Multiple Myeloma Therapeutics Market Share by Application: 2020 VS 2026
Figure 7. Hospitals Case Studies
Figure 8. Clinics Case Studies
Figure 9. Others Case Studies
Figure 10. Multiple Myeloma Therapeutics Report Years Considered
Figure 11. Global Multiple Myeloma Therapeutics Market Size YoY Growth 2015-2026 (US$ Million)
Figure 12. Global Multiple Myeloma Therapeutics Market Share by Regions: 2020 VS 2026
Figure 13. Global Multiple Myeloma Therapeutics Market Share by Regions (2021-2026)
Figure 14. Porter's Five Forces Analysis
Figure 15. Global Multiple Myeloma Therapeutics Market Share by Players in 2019
Figure 16. Global Top Multiple Myeloma Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Multiple Myeloma Therapeutics as of 2019
Figure 17. The Top 10 and 5 Players Market Share by Multiple Myeloma Therapeutics Revenue in 2019
Figure 18. North America Multiple Myeloma Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Europe Multiple Myeloma Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. China Multiple Myeloma Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Japan Multiple Myeloma Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Southeast Asia Multiple Myeloma Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. India Multiple Myeloma Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Central & South America Multiple Myeloma Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Bottom-up and Top-down Approaches for This Report
Figure 26. Data Triangulation
Figure 27. Key Executives Interviewed
多発性骨髄腫に対するCAR-T細胞療法の世界市場（～2026年） CARs are also known as chimeric immunoreceptors, chimeric T-cell receptors, artificial T-cell receptors or CAR T. they are used as an individual's own cells and re-engineers them to fight cancer. Though the market has witnessed several positive results of the clinical trial in the recent years, it i…- 多発性骨髄腫治療の世界市場（～2026年） Multiple myeloma is a cancer formed due to malignant plasma cells. Normal plasma cells are found in the bone marrow and are an important part of the immune system. Plasma cells helps to fight infections by making antibodies that recognize and attack germs. Multiple myeloma causes cancer cells to acc…
- 多発性硬化症における幹細胞治療の世界市場（～2026年） Multiple sclerosis is a nervous system disease, triggered by unidentified environmental factors that adversely affects the brain and spinal cord. It damages the myelin sheath that surrounds and protects the nerve cells. Some of the symptoms of the disease includes weakness, numbness, blurred vision,…
- 多発性硬化症治療薬の世界市場（～2026年） Multiple sclerosis (MS) is a potentially disabling disease of the brain and spinal cord (central nervous system). In MS, the immune system attacks the protective sheath (myelin) that covers nerve fibers and causes communication problems between your brain and the rest of your body. Eventually, the d…
- 多系統萎縮症治療薬の世界市場（～2026年） Market Analysis and Insights: Global Multiple System Atrophy Therapeutics Market The global Multiple System Atrophy Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Multiple System Atrophy Therapeutics Scop…